Nowhere yet.
They have a final dossier apparently about to be formally submitted to FDA for the use of Oncosil under Humanitarian Device Exemption for people with cholangiocarcinoma.
No agreement on pivotal studies for FDA approval for pancreatic cancer as yet
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $13.65M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.03 | 96.0¢ | $12.69K | 13.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1185 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 7827 | 1 |
View Market Depth
| Last trade - 10.30am 18/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |